Hodgkin's and Castleman's disease in a patient with systemic mastocytosis

Annals of Hematology

Volumn 78, Issue 2, 1999, Pages 97-100

  Saletti, P ^a   Ghielmini, M ^a   Cavalli, F ^a   Scali, G ^b   Pedrinis, E ^c   Gueneau M ^d  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b Division of Hematology   (Switzerland)

^c INSTITUTE OF PATHOLOGY   (Switzerland)

^d Ospedale Italiano   (Switzerland)

Author keywords

Castleman's disease; Chemotherapy; Hodgkin's disease; Systemic mastocytosis

Indexed keywords

BLEOMYCIN; METHOTREXATE; VASOACTIVE AGENT; VINBLASTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPH NODE BIOPSY; MALE; MAST CELL; PLASMA CELL; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SYSTEMIC MASTOCYTOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE MARROW; COMBINED MODALITY THERAPY; GIANT LYMPH NODE HYPERPLASIA; HODGKIN DISEASE; HUMANS; LYMPH NODES; MALE; METHOTREXATE; MIDDLE AGED; TUMOR STEM CELLS; URTICARIA PIGMENTOSA; VINCRISTINE;

EID: 0032997467     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050482     Document Type: Article

References (23)

1. Tharp MD (1985) The spectrum of mastocytosis. Am J Med Sci 289:117-132
2. Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG (1988) Significance of systemic mast cell disease with associated hematologic disorders. Cancer 62:965-972
3. Cox JV, Balaban EP, Demian SE, Sheehan RG (1991) An eosinophilic fibrohistiocytic lesion of hone marrow in a patient with Hodgkin's disease. A potential for morphologic confusion. Cancer 68:1824-1827
4. Horning SJ, Hoppe RT, Mason J, Brown BW, Hancock SL, Rosenberg SA (1997) Stanford-Kaiser permanent G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. J Clin Oncol 15:1736-1744
5. Olafsson JH (1985) Cutaneous and systemic mastocytosis in adults. Acta Derm Venereol [Suppl] 115:1-43
6. Horny HP, Kaiserling E, Campbell M, Parwaresch MR, Lennert K (1989) Liver findings in generalized mastocylosis. Cancer 63:532-538
7. Maheswaran PR, Ramsay AD, Norton AJ, Roche WR (1991) Hodgkin's disease presenting with the histological features of Castleman's disease. Histopathology 18:249-253
8. Abdel-Reheim FA, Koss W, Rappaport ES, Arber DA (1996) Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease). Arch Pathol Lab Med 120:91-96
9. Travis WD, Li C-Y, Bergslralli EJ, Yam LT, Swee RG (1988) Systemic mast cell disease: analysis of 58 cases and literature review. Medicine (Baltimore) 67:345-368
10. Cooper AJ, Winkelmann RK, Wiltsie JC (1982) Hematologic malignancies occurring in patients with urticaria pigmentosa. J Am Acad Dermatol 7:215-220
11. Hutchinson RM (1992) Mastocytosis and co-existent non-Hodgkin's lymphoma and myeloproliferative disorders. Leuk Lyraphoma 7:29-36
12. Travis WD, Li CY, Hoagland HC, Travis LB, Banks PM (1986) Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc 61:957-966
13. Horny HP, Parwaresch MR, Kaiserling E, Muller K, Olbermann M, Mainzer K, Lcnnert K (1986) Mast cell sarcoma of the larynx. J Clin Pathol 39:596-602
14. Travis WD, Li CY, Bergstralh EJ (1989) Solid and haematological malignancies in 60 patients with systemic mast cell disease. Arch Pathol Lab Med 113:365-368
15. Travis WD, Li CY (1988) Pathology of the lymph node and spleen in systemic mast cell disease. Med Pathol 1:4-14
16. Kirshenbaum AS, Kessler SW, Goff JP, Metcalte DD (1991) Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 146:1410-1415
17. Ihle JN, et al (1983) Biological properties of homogeneous interleukin-3. Demonstration of WEH1-3 growth factor activity, mast cell growth activity. P cell-stimulating factor activity and histamine-producing factor activity. J Immunol 131:282
18. Macintyre EA, Vaughan Hudson B, Vaughan Hudson G, Jelliffe AM, Linch DC (1987) Incidence and clinical importance of hone marrow eosinophilia in Hodgkin's disease. J Clin Pathol 40:245-246
19. Longley BJ, Morganroth GS, Tyrrell L, et al (1993) Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302-1307
20. Zarate-Osorno A, Medeiros LJ, Danon AD, Neiman RS (1994) Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med 118:270-274
21. Meyers CE, Chabner BA, DeVita VT, Gralnik HR (1974) Bone marrow involvement in Hodgkin's disease: pathology and response to MOPP chemotherapy. Blood 44:197-204
22. Hutchinson RM, King PHM (1991) Blood findings in generalized mastocytosis: coexistent non-Hodgkin's lymphoma. Br J Haematol 77:436-442
23. Kluin-Nelemans HC, Jansen JH, Breukelman H, Wolthers BG, Kluin PM, Kroon HM, Willemze R (1992) Response to interferon alpha-2b in a patient with systemic mastocytosis. N Engl J Med 326:619-623